Keyphrases
Between-study Variance
11%
Biochemical Markers
100%
C-statistic
22%
Characteristic Markers
44%
Characteristic Model
11%
Clinical Characteristics
77%
Clinical Markers
100%
Clinical Ultrasound
11%
Clinical Utility
22%
Confidence Interval
11%
Decision Curve Analysis
11%
Early Identification
11%
Early Onset
11%
Early-onset Preeclampsia
11%
First Trimester
33%
High-risk Women
11%
History of Hypertension
11%
In-the-large
11%
Individual Participant Data
11%
Individual Participant Data Meta-analysis
100%
International Survey
11%
Late-onset
11%
Maternal Mortality
11%
Mode of Conception
11%
Model Overfitting
11%
Neonatal Morbidity
11%
Net Benefit
33%
Nulliparous Women
11%
Odds Ratio
11%
Performance Prediction
22%
Perinatal Mortality
11%
Placental Growth Factor (PlGF)
11%
Population Characteristics
11%
Population Heterogeneity
11%
Prediction Interval
11%
Prediction Model
33%
Prediction of Preeclampsia
11%
Preeclampsia
100%
Pregnancy Complications
44%
Pregnancy Prediction
44%
Prognostic Value
22%
Random-effects Meta-analysis
11%
Second Trimester
33%
Secondary Care
11%
Singleton
22%
Singleton Pregnancy
11%
Source Data
11%
Specific Performance
11%
Tertiary Care
11%
UK NHS
11%
Ultrasound Markers
100%
Uterine Artery Pulsatility Index
11%
Validation Cohort
11%
Medicine and Dentistry
Biochemical Marker
27%
Cohort Analysis
9%
Complication of Pregnancy
36%
Conception
9%
First Trimester Pregnancy
27%
Labor Onset
18%
Maternal Mortality
9%
Meta-Analysis
100%
Nulliparous
18%
Odds Ratio
9%
Perinatal Morbidity
9%
Perinatal Mortality
9%
Placental Growth Factor
9%
Population and Population Related Phenomena
9%
Pre-Eclampsia
100%
Pregnancy
18%
Pulsatility Index
9%
Second Trimester Pregnancy
27%
Secondary Care
9%
Study Heterogeneity
9%
Systematic Review
18%
Tertiary Care
9%
Uterine Artery
9%
Biochemistry, Genetics and Molecular Biology
Cohort Study
9%
Conception
9%
Eclampsia
100%
First Trimester Pregnancy
27%
Labor Onset
18%
Maternal Mortality
9%
Perinatal Morbidity
9%
Perinatal Mortality
9%
Placental Growth Factor
9%
Population and Population Related Phenomena
9%
Pregnancy
18%
Second Trimester Pregnancy
27%
Pharmacology, Toxicology and Pharmaceutical Science
Biochemical Marker
27%
Cohort Study
9%
Maternal Mortality
9%
Perinatal Morbidity
9%
Perinatal Mortality
9%
Placental Growth Factor
9%
Population Study
9%
Preeclampsia
100%
Pregnancy Complication
36%